121 reports of this reaction
3.6% of all NITROUS OXIDE reports
#3 most reported adverse reaction
CARDIAC ARREST is the #3 most commonly reported adverse reaction for NITROUS OXIDE, manufactured by AGL Welding Supply Co., Inc.. There are 121 FDA adverse event reports linking NITROUS OXIDE to CARDIAC ARREST. This represents approximately 3.6% of all 3,365 adverse event reports for this drug.
Patients taking NITROUS OXIDE who experience cardiac arrest should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CARDIAC ARREST is moderately reported among NITROUS OXIDE users, representing a notable but not dominant share of adverse events.
In addition to cardiac arrest, the following adverse reactions have been reported for NITROUS OXIDE:
The following drugs have also been linked to cardiac arrest in FDA adverse event reports:
CARDIAC ARREST has been reported as an adverse event in 121 FDA reports for NITROUS OXIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
CARDIAC ARREST accounts for approximately 3.6% of all adverse event reports for NITROUS OXIDE, making it one of the most commonly reported side effect.
If you experience cardiac arrest while taking NITROUS OXIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.